| # | Drug | Count |
|---|---|---|
| 0 | LAMIVUDINE | 1902 |
| 1 | LAMIVUDINE ORAL | 1902 |
| 2 | EFAVIRENZ | 958 |
| 3 | TENOFOVIR DISOPROXIL FUMARATE | 836 |
| 4 | RITONAVIR | 809 |
| 5 | NEVIRAPINE | 800 |
| 6 | ZIDOVUDINE | 778 |
| 7 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 744 |
| 8 | RITONAVIR 100 MG | 685 |
| 9 | ABACAVIR SULFATE | 490 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NEVIRAPINE | 800 | 0.0890 |
| 1 | EFAVIRENZ | 958 | 0.0863 |
| 2 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 744 | 0.0860 |
| 3 | RALTEGRAVIR | 438 | 0.0835 |
| 4 | LAMIVUDINE | 1902 | 0.0753 |
| 5 | ZIDOVUDINE | 778 | 0.0750 |
| 6 | EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE | 2 | 0.0667 |
| 7 | CABOTEGRAVIR AND RILPIVIRINE | 434 | 0.0663 |
| 8 | BULEVIRTIDE | 6 | 0.0625 |
| 9 | RILPIVIRINE | 445 | 0.0623 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1709 | 0.0711 |
| 1 | CCR5 Co-receptor Antagonist [EPC] | 141 | 0.0615 |
| 2 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2168 | 0.0441 |
| 3 | CD4-directed Blocking Antibody [EPC] | 18 | 0.0333 |
| 4 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2797 | 0.0254 |
| 5 | Protease Inhibitor [EPC] | 960 | 0.0216 |
| 6 | Cytochrome P450 3A Inhibitor [EPC] | 964 | 0.0159 |
| 7 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 165 | 0.0031 |
| 8 | Nucleoside Analog Antiviral [EPC] | 242 | 0.0028 |
| 9 | Rifamycin Antimycobacterial [EPC] | 9 | 0.0026 |